Profile
Barry Porter was the Chief Executive Officer of ReOx Ltd.
and Union Life Sciences Ltd.
He was also a Non-Executive Director at Oxford Drug Design Ltd.
and Avacta Group Plc from 2009 to 2011.
Additionally, he served as a Director at IR 2018 Ltd.
from 2013 to 2018.
Former positions of Barry Porter
| Companies | Position | End |
|---|---|---|
IR 2018 Ltd.
 IR 2018 Ltd. Miscellaneous Commercial ServicesCommercial Services IR 2018 Ltd. develops human proteins for the treatment of rheumatoid arthritis. The company was founded by Gabriel S. Panayi and Jerry S. Lanchbury in August 6, 2001 and is headquartered in Great Shelford, the United Kingdom. | Director/Board Member | 2018-01-03 |
| AVACTA GROUP PLC | Director/Board Member | 2011-03-16 |
Union Life Sciences Ltd.
 Union Life Sciences Ltd. BiotechnologyHealth Technology Union Life Sciences Ltd. provides healthcare services. The company is headquartered in London, the United Kingdom. | Chief Executive Officer | - |
Oxford Drug Design Ltd.
 Oxford Drug Design Ltd. Packaged SoftwareTechnology Services Oxford Drug Design Ltd. develops application of new technologies to drive computer-aided drug discovery. It specializes in drug discovery, molecular modeling, lead identification and optimisation, formulation modeling and preclinical studies. The company was founded by W. Graham Richards in 2001 and is headquartered in Oxford, the United Kingdom. | Director/Board Member | - |
ReOx Ltd.
 ReOx Ltd. Pharmaceuticals: MajorHealth Technology ReOx Ltd. discovers and develops drugs. It provides novel treatments for disease by controlling the actvity of hypoxia inducible factor. The company was founded by Christopher W. Pugh, Patrick Maxwell, Peter J. Ratcliffe, and Christopher J. Schofield in June 2003 and is headquartered in Thame, the United Kingdom. | President | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AVACTA GROUP PLC | Commercial Services |
| Private companies | 4 |
|---|---|
Oxford Drug Design Ltd.
Oxford Drug Design Ltd. Packaged SoftwareTechnology Services Oxford Drug Design Ltd. develops application of new technologies to drive computer-aided drug discovery. It specializes in drug discovery, molecular modeling, lead identification and optimisation, formulation modeling and preclinical studies. The company was founded by W. Graham Richards in 2001 and is headquartered in Oxford, the United Kingdom. | Technology Services |
ReOx Ltd.
ReOx Ltd. Pharmaceuticals: MajorHealth Technology ReOx Ltd. discovers and develops drugs. It provides novel treatments for disease by controlling the actvity of hypoxia inducible factor. The company was founded by Christopher W. Pugh, Patrick Maxwell, Peter J. Ratcliffe, and Christopher J. Schofield in June 2003 and is headquartered in Thame, the United Kingdom. | Health Technology |
IR 2018 Ltd.
IR 2018 Ltd. Miscellaneous Commercial ServicesCommercial Services IR 2018 Ltd. develops human proteins for the treatment of rheumatoid arthritis. The company was founded by Gabriel S. Panayi and Jerry S. Lanchbury in August 6, 2001 and is headquartered in Great Shelford, the United Kingdom. | Commercial Services |
Union Life Sciences Ltd.
Union Life Sciences Ltd. BiotechnologyHealth Technology Union Life Sciences Ltd. provides healthcare services. The company is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Barry Porter
